Literature DB >> 7408910

Hypoketosis as a cause of symptoms in childhood hypoglycemia.

H L Teijema, H H van Gelderen, M A Giesberts.   

Abstract

Children with symptomatic hypoglycemia and asymptomatic hypoglycemia-prone children were shown to differ in the degree of ketosis after a 20 h fast. In the latter children the close negative correlation between ketone body levels and glucose levels yielded a regression line against which the former children's data could be compared. Half of the patients were found to be hypoketotic during hypoglycemia. The significance of this hypoketosis in the symptomatology is discussed. The finding of other abnormal responses to fasting, particularly in the patients' nitrogen metabolism, suggests that all these aberrations have a common cause which may be of hepatic origin.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7408910     DOI: 10.1007/bf00442403

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  16 in total

1.  Enzymic determination of D(-)-beta-hydroxybutyric acid and acetoacetic acid in blood.

Authors:  D H WILLIAMSON; J MELLANBY; H A KREBS
Journal:  Biochem J       Date:  1962-01       Impact factor: 3.857

2.  A rapid and precise method for the determination of urea.

Authors:  J K FAWCETT; J E SCOTT
Journal:  J Clin Pathol       Date:  1960-03       Impact factor: 3.411

3.  Quantitative aspects of the reaction between insulin and insulin-binding antibody.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

4.  Hyperinsulinism in infancy: diagnosis by demonstration of abnormal response to fasting hypoglycemia.

Authors:  C A Stanley; L Baker
Journal:  Pediatrics       Date:  1976-05       Impact factor: 7.124

Review 5.  The glucose-alanine cycle.

Authors:  P Felig
Journal:  Metabolism       Date:  1973-02       Impact factor: 8.694

6.  Response to 2-deoxy-D-glucose and to glucagon in "ketotic hypoglycemia" of childhood: evidence for epinephrine deficiency and altered alanine availability.

Authors:  P C Sizonenko; L Paunier; B Vallotton; G S Cuendet; G Zahnd; E B Marliss
Journal:  Pediatr Res       Date:  1973-12       Impact factor: 3.756

7.  Origin and possible significance of alanine production by skeletal muscle.

Authors:  R Odessey; E A Khairallah; A L Goldberg
Journal:  J Biol Chem       Date:  1974-12-10       Impact factor: 5.157

8.  Dicarboxylic aminoaciduria: an inborn error of glutamate and aspartate transport with metabolic implications, in combination with a hyperprolinemia.

Authors:  H L Teijema; H H van Gelderen; M A Giesberts; M S Laurent de Angulo
Journal:  Metabolism       Date:  1974-02       Impact factor: 8.694

9.  Regulation of glucose and ketone-body metabolism in brain of anaesthetized rats.

Authors:  N B Ruderman; P S Ross; M Berger; M N Goodman
Journal:  Biochem J       Date:  1974-01       Impact factor: 3.857

10.  Hypoglycemia in children.

Authors:  B Senior; J I Wolfsdorf
Journal:  Pediatr Clin North Am       Date:  1979-02       Impact factor: 3.278

View more
  4 in total

1.  beta-Hydroxybutyrate fuels synaptic function during development. Histological and physiological evidence in rat hippocampal slices.

Authors:  Y Izumi; K Ishii; H Katsuki; A M Benz; C F Zorumski
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

2.  Systemic carnitine deficiency: benefit of oral carnitine supplements vs. persisting biochemical abnormalities.

Authors:  M Duran; J B de Klerk; S K Wadman; H R Scholte; R P Beekman; F G Jennekens
Journal:  Eur J Pediatr       Date:  1984-08       Impact factor: 3.183

3.  Fat-derived fuels during a 24-hour fast in children.

Authors:  J I Wolfsdorf; A Sadeghi-Nejad; B Senior
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183

4.  Glutaric aciduria type II: treatment with riboflavine, carnitine and insulin.

Authors:  P D Mooy; H Przyrembel; M A Giesberts; H R Scholte; W Blom; H H van Gelderen
Journal:  Eur J Pediatr       Date:  1984-12       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.